In previous studies we reported that although morphine dose dependently inhibits noxious stimulus-evoked expression of the c-fos proto-oncogene in the rat spinal cord, morphine was without effect in certain populations of presumed nociresponsive neurons, even under conditions of complete behavioral analgesia. To determine whether the neurons that continue to express the c-fos gene include projection neurons, we evaluated the effect of morphine on noxious stimulus-evoked c-fos expression in spinoparabrachial neurons retrogradely labeled with Fluoro-gold.
In the formalin test, we found that morphine analgesia was associated with a significant reduction in the number of Fos-like-immunoreactive spinoparabrachial projection neurons in the lateral reticulated area of the neck of the dorsal horn. Morphine, however, did not reduce the number of Fos-like-immunoreactive spinoparabrachial projection neurons either in the superficial dorsal horn or in the area around the central canal. These results indicate that under conditions of morphine analgesia two distinct populations of spinoparabrachial neurons can be recognized on the basis of their expression of the c-fos gene in response to noxious stimulation.
Since the expression of the c-fos gene has been correlated with neuronal activity, these data suggest that activity, and central transmission of nociceptive information, persists in certain nociresponsive projection neurons during morphine analgesia. Alternatively, if activity has, in fact, been blocked in these neurons, our results indicate that injury can produce significant molecular changes in neurons even though the neuronal activity and pain associated with the injury is blocked by morphine.
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Opioids produce their analgesic effect through actions at multiple sites in the CNS (Yaksh and Noueihed, 1985) . At supraspinal sites, morphine binds to opioid receptors in the midbrain periaqueductal gray (PAG) and activates a descending inhibitory control system that modulates the firing of spinal cord and trigeminal nociresponsive neurons (Basbaum and Fields, 1984) . At the spinal cord level, morphine directly inhibits the firing of dorsal horn nociresponsive neurons, and it can presynaptically regulate the release of neurotransmitters from primary afferent nociceptors (Aimone and Yaksh, 1989) . Although many spinal cord nociresponsive neurons that project to supraspinal sites are inhibited by opioids (Juma and Grossman, 1976; Willcockson et al., 1984; Hylden and Wilcox, 1986; Dickenson and Sullivan, 1987) , in fact it has not been established whether populations of projection neurons are inhibited during behavioral analgesia induced by systemically administered opioids. Numerous studies have demonstrated the utility of following the expression of the c-fos proto-oncogene to monitor stimulation modality-specific activation of neuronal subpopulations (Hunt et al., 1987; Menttrey et al., 1989; Bullitt, 199 1; Campeau et al., 1991; Brennan et al., 1992; Traub et al., 1992) . For example, we recently reported that a persistent non-noxious stimulus, evoked by walking on a rotating rod for 1 hr, produces a very distinct pattern of Fos labeling in the spinal cord (Jasmin et al., 1994) that includes regions that contain neurons with predominant innocuous mechanoreceptive inputs, namely, the inner part of the substantia gelatinosa (lamina III), the nucleus proprius (laminae III and IV), and the medial part of the neck of the dorsal horn. In contrast to walking, noxious stimulation evokes a very different pattern of C-$X expression in the spinal cord (Hunt et al., 1987; Menetrey et al., 1989; Bullitt, 1990) . In our studies, hindpaw formalin injection evoked increased Fos labeling in areas where physiological studies (Menttrey, 1987) have identified nociresponsive neurons: (1) the superficial laminae (I and 110) of the dorsal horn, as defined by Molander et al. (1984) (2) the lateral reticulated area of the neck of the dorsal horn, as defined by Steiner and Turner (1972) (3) the area around the central canal, and (4) the ventral horn, in laminae VII and VIII.
Although we demonstrated that the number of Fos-like-immunoreactive neurons evoked by formalin correlates highly with the magnitude of the pain behavior that it elicited (Gogas et al., 199 l) , we also found that behavioral analgesia could be produced without completely blocking the formalin-induced expression of c-fis (Presley et al., 1990) . Specifically, although morphine profoundly reduced c-fos expression in the reticulated area of the dorsal horn and in the ventral horn, the inhibition never exceeded 60% in the superficial dorsal horn. Our studies did not determine whether the subpopulation of dorsal horn neurons that continue to express c-fos during morphine anal-gesia includes projection neurons; all of the residual Fos-like immunoreactivity could have been in interneurons. This question is important because the neuronal circuits that could be influenced by the downstream consequences of injury-evoked c-fos expression under conditions of morphine analgesia are very different if the projection neurons are involved.
In the present study we specifically investigated the effects of morphine on Fos-like-immunoreactive spinal cord neurons that project to the parabrachial region. The parabrachial rather than spinothalamic projecting neurons were chosen because many of their cell bodies are located in areas of the cord where the morphine-resistant, noxious stimulus-evoked, Fos-like immunoreactivity was found, that is, in the superficial dorsal horn (laminae I and 110). Neurons in the lateral reticulated area of the dorsal horn and in the area around the central canal (Menetrey and de Pommery, 1991; Kitamura et al., 1993) are also at the origin of the spinoparabrachial pathway. We first retrogradely labeled the spinoparabrachial neurons and then evaluated the effect of morphine on noxious stimulus-evoked Fos-like immunoreactivity in these projection neurons. We report that under conditions of behavioral analgesia, a large population of spinoparabrachial neurons continues to show increased c-fos expression in response to noxious stimulation. Drugs. Morphine sulfate (Wyeth Laboratories, Philadelphia, PA) or its vehicle was given subcutaneously in two doses: 30 min (10 m&g) and 1.0 min (5.0 mg/kg) before the formalin iniection. The opioid antagonist naltrexoney when used, was given subcutaneously (16 mg/ kg) 5 min before the first dose of morphine, that is, 35 min before the noxious stimulus.
Materials and Methods
Twenty-two male Sprague-Dawley rats (270-300 gm; Bantin and Kingman) were used in the study. All animals were exposed to light 12 hr/ d; food and water were available ad libitum. Procedures for the maintenance and use of the experimental animals conformed to the regulations of the UCSF Committee on Animal Research and were carried out in accordance with the guidelines of the NIH regulations on animal use.
To verify that injection of the tracer does not, by itself, induce c-fis expression, one animal received neither drugs nor nociceptive stimulation and was perfused 1 week after Fluoro-gold injection. Three animals received morphine, without noxious stimulation, and were perfused 1 hr later to verify that the drug by itself does not induce c-jhs expression. The 18 remaining animals underwent the formalin test (Dubuisson and Dennis, 1977) 1 week after injection of Fluoro-gold into the right parabrachial area. Twelve ofthe rats received morphine before the formalin injection; six controls received saline before the formalin. Two of the morphine/formalin animals also received naltrexone prior to any other treatment.
_ Formalin'test. Rats were acclimated to the environment and then eentlv restrained and aiven a subcutaneous iniection of 100 ul of 5% Surgery. During the surgical procedure, the animals were maintained under deep anesthesia with a mixture of ketamine (60 mg/kg) and xylazine (7.0 mg/kg) injected intramuscularly. For surgeries that lasted more than 40 min an additional dose of ketamine (20 mg/kg) was given. Animals were placed in a stereotaxic apparatus (David Kopf Instruments, Germany) using nonperforating ear bars. Coordinates (rostrocaudal -0.16, mediolateral2.1, dorsoventral6.3) were taken from Paxinos and Watson's (1986) atlas using the interaural point as zero. A small burr hole was made above the target, the dura matter was opened, and then 20-40 nl of 4.0% or 8.0% Fluoro-gold (Fluorochrome Inc., CO), dissolved in double-distilled water, was slowly injected into the right pontine lateral parabrachial area using a glass micropipette with a tip diameter of 40 pm fixed to a 1 ~1 Hamilton syringe. The pipette was left in place for 15 min after the injection to reduce tracer leakage along the injection track. After recovering from surgery, the animals were returned to the animal care facility for 7 d, which was sufficient time for maximal retrograde transport of the Fluoro-gold to the lumbar soinal cord (Schmued and Fallon, 1986) .
Perfusion. At the end of the testing period, each animal was deeply anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (15 mg/kg), and then perfused through the ascending aorta with 50 ml of 0.05 M phosphate-buffered 0.9% saline (PBS), followed by 750 ml of 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, at room temperature. Two hours later, the spinal cord and brainstem were removed and postfixed in the same fixative solution for 4 hr at 4°C. The tissues were then cryoprotected in a 30% solution of phosphate-buffered (pH 7.4) sucrose at 4°C for at least 48 hr before sectioning.
Zmmunocytochemistry. Fifty-micrometer serial transverse sections of the injection site and of the lumbar spinal cord were cut on a freezing microtome. Every fourth section was immunostained. To visualize Foslike-immunoreactive neurons in the spinal cord, we used the avidinbiotin-peroxidase procedure (Hsu et al., 198 1) as previously described (Presley et al., 1990) . Sections of the lumbar cord were immersed in a blocking solution made of 3% normal goat serum (NGS) and 0.3% Triton X-100 in PBS for 1 hr and then incubated for 48 hr at 4°C with a rabbit polyclonal antiserum directed against an in vitro translated protein product of the c-fos gene (courtesy of Dr. Dennis Slamon, Departments of Hematology and Oncology, UCLA) at a dilution of 1:2 1,000 in PBS, 1% normal goat serum, and 0.3% Triton. This antiserum does not recognize the Fos-related antigens. To reduce background staining, the antiserum was preabsorbed with acetone-dried rat liver powder for 1 hr at 37°C and 2 hr at 4°C. After the primary antibody incubation, the tissue was exposed to a goat anti-rabbit biotinylated secondary IgG (Vector Labs, Burlingame, CA) diluted 1:200 and then to the ABC Elite complex (Vector Labs) for 1 hr at room temperature. To visualize the Fos-like immunoreactivity as a black reaction product we used a nickeldiaminobenzidine (Nickel-DAB) glucose-oxidase reaction following a protocol adapted from Llewellyn-Smith and Minson (1992).
anti-Fluoro-gold polyclonal antiserum (Chemicon Inc:, Temecula, CA) at a dilution of 1:5000-1:20.000. denendina on the lot. After washina.
The same Fluoro-gold immunocytochemical procedure was used to identify injection sites (Figs. 1,2) and retrogradely labeled neurons (Figs. 3, 4) . For double labeling, the Fos-immunoreacted sections were washed three times in Tris buffer with 1% NGS and 0.3% Triton and incubated with the blocking solution for 1 hr, and then overnight with a rabbit
formalin (Sigma, St. L&is, MO), in water, into-the distal plan& region of the left hind paw; injections were made with a 30 gauge needle. The behavior of the animals was then continuously monitored for a period of 60 min. Since we were interested in the distribution of Fos immunoreactivity under conditions ofcompletebchavioral analgesia, we monitored the rats to ensure that the morphine effect was complete.
the tissue was exposed to a goat anti:rabbitbiotinylated secondary IgG and then to the ABC complex. The FIuoro-gold-like immunoreactivity was made visible by DAB reaction as described above, with the exclusion of nickel. The two immunocytochemical procedures resulted in a light brown staining of the cytoplasm of retrogradely labeled neurons that contrasted well with the black nuclei of the Fos-like-immunoreac- Figure 2 . These camera lucida drawings of transverse sections show the extent of the Fhtoro-gold injections in the parabrachial area in three representative cases, FL-I 11, n-129, and n-91. CNF, cuneiform nucleus; IC, inferior colliculus; IV. fourth ventricle; MCP, middle ceretxllar peduncle; Mo5, motor nucleus of the trigeminal; PAG, periaqueductal gray matter; SCP, middle cerebellar peduncle.
tive neurons (Fig. 3 ) and allowed identification of double-labeled cells over a wide range of staining intensity for both antigens. Finally, sections were washed three times in Tris buffer, mounted from tap water on gelatin-coated slides, air dried, dehydrated in alcohol in graded manner, cleared in xylene, and coverslipped. The injection sites were visualized by reacting the brainstem sections with the anti-Fluoro-gold antiserum following the steps described above, and completing the procedure with a nickel-intensified DAB reaction, Omitting the primary antiserum for the Fos protein or Fluoro-gold on control sections resulted in no signal for the corresponding antigen. For each antigen, comparison of cell counts made in single-and doublelabeled sections from the same animal confirmed that the double immunocytochemistry did not reduce the signal of individual antigens.
We used immunocytochemistry with an ABC technique, rather than fluorescence, to detect Fos and Fluoro-gold. Although fluorescence detection is simpler, the signal of Fos-like immunoreactivity after the Ni-DAB reaction is much stronger than that seen after an indirect fluorescence method. Furthermore, immunostaining the Fluoro-gold makes double-labeled cells easier to detect under the microscope at both high and low magnification. In a preliminary study, we found that the fluorescence method led to an underestimation of the number of doublelabeled cells.
Mapping and cell counts. AI1 drawings of sections were done under light microscopy, using a camera lucida attachment. The full extent of the injection site and the surrounding brainstem were mapped at low magnification (4 x ). For the spinal cord, counts of single-labeled Fos or Pluoro-gold and double-labeled cells were made on six randomly selected L,-L, sections for each of the I8 formalin-injected animals. The investigator responsible for plotting and counting the labeled cells was blind to the drug treatment of each animal. The following three regions of the spinal gray matter (Steiner and Turner, 1972; Molander et al., 1984) were delineated on the spinal cord drawing: (1) laminae I + 110, (2) reticulated area of the dorsal horn (delineated under dark-field illumination), and (3) the central canal area (lamina X and adjacent portions of laminae V, VI, VII, and VIII; Fig. 4 ). These three lumbar cord regions contain the majority of the neurons that project to the parabrachial nucleus (PBN) (Menttrey and de Pommery, 1991) . Although the lateral spinal nucleus also contained neurons that projected to the PBN, we excluded these neurons from the present analysis because few ofthese cells expressed c-fos in response to formalin. Nociresponsive neurons in laminae VII and VIII were also excluded because very few of these project to the PBN.
Since a quantitative study of double-labeled Fluoro-gold and Foslike-immunoreactive neurons has never been reported before, the strict criteria used to map single-and double-labeled cells will be described. A nucleus was counted as Fos positive if it was entirely filled by black reaction product. A cell body was counted as Pluoro-gold positive if the granular brown reaction product surrounded a nuclear area and filled the proximal dendrites. Fluoro-gold-like-immunoreactive cells whose nuclei contained a brown reaction product were occasionally seen, but were not considered to be double labeled since the nuclear immunoreactivity may have resulted from Fluoro-gold rather than Fos. All cells were identified, mapped, and counted at high magnification (2wO x). For all animals, we express the extent of double labeling as a percentage ofthe total number ofretrogradely labeled cells. This calculation corrects for differences in the absolute number of retrograde cells that probably resulted from differences in the location of the Fluoro-gold injection sites.
Sfutisficul analysis. The results are presented as means -t SEM. Statistical comparisons were performed using the Student's t test (unpaired, two tailed) to compare the means of the two groups. Differences between means were considered statistically significant at P -C 0.05.
Results

Control experiments
As described previously (Presley et al., 1990) , in unstimulated rats we typically record some lightly labeled Fos-likcimmunoreactive neurons in laminae III and IV, these neurons are presumably driven by large-diameter primary afferent fibers that have cutaneous inputs. The same pattern was observed in the present study and, importantly, it did not differ in an animal that was injected in the parabrachial nucleus 1 week prior to perfusion but was not exposed to the noxious stimulus, or in the three animals that received morphine without the noxious stimulus. Thus, the presence of retrogradely transported Fluorogold in spinal neurons does not itself induce Fos-like immunoreactivity. Comparable results were previously obtained with a different retrograde tracer (Menetrey et al., 1989) . Unless otherwise noted, the counts of labeled cells per 50 pm section for the different spinal cord regions include only cells on the side contralateral to the Fluoro-gold injection.
Injection sites in the parabrachial area In a preliminary study, we established that injections in the lateral parabrachial area produced more retrogradely labeled cells in the superficial dorsal horn than did injections in either the thalamus or the caudal medulla. Injections near to, but excluding, the lateral parabrachial area resulted in minimal retrograde labeling of cells in the superficial dorsal horn. Thus, we have analyzed only cases in which the injection site included part or all of the lateral parabrachial area (Fig. 1) . Adjacent nuclei that were occasionally involved in the injection site were the ventral third of the inferior colliculus, the cuneiform nucleus, the dorsal nucleus of the lateral lemniscus, the principal sensory trigeminal nucleus, and lobule II of the cerebellum. passage in the superior cerebellar peduncle, the ventral spinocerebellar tract, and the lateral lemniscus were also frequently involved. To our knowledge, however, axons from the superficial dorsal horn do not course in these fiber tracts. Importantly, the injection sites never encroached upon the location of the spinothalamic tract, which is located more ventrally (H. J. Ralston III, personal communication).
Distribution of Fluoro-gold-immunoreactive neurons
With the exception of the lateral spinal nucleus, which was labeled on both sides of the spinal cord, Fluoro-gold-positive neurons predominated on the side of the spinal cord contralatera1 to the injection site, in the superficial dorsal horn, in the reticulated area of the dorsal horn, and in the area around the central canal. This is consistent with previous reports (Menetrey and de Pommery, 199 1; Kitamura et al., 1993) . The average number of Fluoro-gold-labeled cells per 50 pm section of L,-L, spinal cord was 7.4 f 0.6 ipsilateral to the Fluoro-gold injection, and 18.0 ? 1.0 contralaterally (n = 20). With respect to the laminar distribution on the contralateral side, we recorded 6.2 + 0.3 neurons in laminae I + 110, and 3.1 + 0.2 neurons in the reticulated area of the dorsal horn. There were 4.1 f 0.4 neurons located bilaterally around the central canal. The other retrogradely labeled neurons were dispersed in the ventral and dorsal horns. Although Fluoro-gold-immunoreactive neurons in laminae I and 110 were found throughout the mediolateral extent of the superficial dorsal horn, 80% were located in its middle third, where many were clustered under the dorsal root entry zone (Fig. 3) . In the reticulated area of the dorsal horn, most of the retrogradely labeled cells were located laterally, at the junction of gray matter and white matter (Fig. 3) .
Eflect of formalin injection in control, saline-treated rats: behavior, Fos-like immunoreactivity, and double labeling from the parabrachial region Fifteen seconds after the formalin injection the animals began to display the behavior that characterizes the first phase of the formalin test: flinching, shaking, licking and biting of the injected paw, and frequent movement within the observation area (Dubuisson and Dennis, 1977 ; Wheeler-Aceto and Cowan, 199 1). After 5 min, this behavior waned and gave way to a quiescent period during which the animals paid much less attention to the injected paw and had reduced locomotor activity compared to phase I. After 10-15 min, the second phase of the formalin test appeared; it was mainly characterized by the animal's tendency to avoid supporting weight on the affected paw. In control rats, this later phase continued until the end of the 1 hr test period. Based on previous studies in which the pain behavior was scored (Gogas et al., 199 1) , this behavior corresponds to a rating of approximately 2.2 over the 1 hr test period. The distribution of Fos-like immunoreactivity in the lumbar cord of both the formalin-injected rats that received saline was similar to that described previously (Presley et al., 1990) . We recorded the highest density of Fos-like-immunoreactive cells (117.0 + 8.1 neurons per 50-Frn-thick transverse section) in the superficial dorsal horn ipsilateral to the formalin injection (n = 6). Two-thirds of these cells were located in lamina I and the other third in lamina 110. In both of these laminae, the majority of the Fos-like-immunoreactive cells was located in the medial half of the dorsal horn (Figs. 3,4) , where primary afferents from the sciatic nerve terminate (Swett and Woolf, 1985) . Other Foslike-immunoreactive neurons in the ipsilateral spinal cord were located in the reticulated area of the dorsal horn (74.0 ? 13.8) and around the central canal (63.2 ? 14.0).
We recorded double-labeled, that is, Fluoro-gold-and Foslike-immunoreactive, neurons in all areas of the L,-L, spinal segments that contained cells at the origin of the spinoparabrachial projection (Figs. 3, 4) . In the superficial dorsal horn, 55.0 + 5.6% of the retrogradely labeled cells were Fos-like immunoreactive. In the reticulated area of the dorsal horn and in the central canal area, 61.0 -t 4.2% and 22.3 f 2.8%, respectively, of the retrogradely labeled neurons were Fos-like immunoreactive. As expected from the fact that the percentage of labeled superficial dorsal horn (SDH) neurons rapidly falls off rostra1 and caudal to the L,-L, segments, in the L, and L, segments we found an abrupt decrease in the percentage of projection neurons that were double labeled.
Effect of morphine on formalin-evoked behavior, Fos-like immunoreactivity, and double labeling from the parabrachial region Morphine pretreatment completely blocked formalin-evoked pain behavior. Flinching and licking of the paw were absent and, despite the relatively high concentrations of morphine, the rats walked normally, bearing weight on all four limbs. Naltrexone given 5 min before the first dose of morphine, and 35 min before the formalin injection, reversed this analgesia. The pain behavior was similar to that seen in the formalin-injected rats that received saline pretreatment.
As described previously (Presley et al., 1990) , morphine treatment significantly reduced the numbers of Fos-like-immunoreactive neurons in all regions; the largest relative decrease was in more ventral regions of the dorsal horn. In the L,-L, spinal
The Journal of Neuroscience, December 1994, 14(12) 7257 cord, ipsilateral to formalin injection, we recorded 25.7 f 2.8 and 26.0 -t 1.4 Fos-like-immunoreactive cells in the reticulated area of the dorsal horn and in the central canal area, respectively (n = 10). This represented a significant (p < 0.01) reduction in labeling, relative to saline pretreated animals, of 65.0% in the reticulated area of the dorsal horn and 59.0% around the central canal. In the ipsilateral superficial dorsal horn we recorded 64.0 + 7.1 Fos-like-immunoreactive cells per section, which corresponds to a smaller (45%) but still significant (p < 0.01) reduction in the number of Fos-like-immunoreactive cells with morphine. As in the saline-treated animals, two-thirds of the Fos-like immunoreactivity in the superficial dorsal horn was located in lamina I; the remainder was located in lamina 110. In both laminae the highest concentration of labeling was in the medial half of the superficial dorsal horn (Figs. 3, 4) . Finally, we found that the inhibitory effect of morphine on induction of Fos-like immunoreactivity by noxious stimulation was completely reversed by prior administration of the opioid receptor antagonist naltrexone (10 mg/kg, s.c.; n = 2).
In contrast to the relatively uniform inhibition of c-fos expression in the superficial dorsal horn, in the reticulated area of the dorsal horn and in the area around the central canal we found a significant difference in the susceptibility of Fos-likeimmunoreactive spinoparabrachial projection neurons. Thus, relative to saline, morphine significantly (p < 0.01) decreased the percentage of projection neurons that were double labeled in the reticulated area of the dorsal horn (35.7 + 6.6%). This represents an almost 50% reduction in the incidence of double labeling of projection neurons. By contrast, in neither the superficial dorsal horn nor in the area around the central canal did we record a change in the proportion of Fluoro-gold cells that were double labeled. In the SDH, we found that 50.3 & 3.1% of the retrogradely labeled cells were double labeled after morphine treatment; the percentage of projection cells around the central canal that were double labeled after morphine was 17.3 + 2.2%. For both these regions the percentages are not significantly different from what was found in the absence of morphine (p > 0.05). When naltrexone was coadministered with morphine, it not only reversed the inhibition of pain behavior but also reversed the inhibition of c-fos expression in projection cells of the reticulated area of the dorsal horn.
Discussion
In this article we present evidence that two distinct populations of spinoparabrachial neurons can be recognized on the basis of their expression of the c-fos proto-oncogene in response to noxious stimulation (hindpaw formalin injection). In one population, located in the reticulated area of the dorsal horn, the expression of c-fos in spinoparabrachial neurons was significantly reduced by morphine. In contrast, there is a population of parabrachial projection neurons in the superficial dorsal horn and in the area around the central canal that continues to express the gene even though the dose of morphine used was sufficient to produce complete behavioral analgesia. Since morphine, by itself, does not evoke increases in C-&X expression in spinal cord neurons (Presley et al., 1990; present results) , at least two possible explanations for our results can be proposed. First, the increased FL1 in projection neurons raised the possibility that under conditions of morphine analgesia, nociresponsive spinoparabrachial cells still transmit information to the brainstem. This hypothesis is based on the evidence that increased c-fos expression parallels neuronal activity (evoked under physiological conditions in vivo, or by ligand interactions in vitro) (Hunt et al., 1987; Morgan et al., 1987; Dragunow and Faull, 1989; Menetrey et al., 1989; Bullitt, 1990; Sheng and Greenberg, 1990; Herdegen et al., 1991) . The second hypothesis is based on the premise that neuronal activity and Fos expression are, in fact, dissociated in these neurons. That is, if activity in these neurons is blocked by the analgesic dose of morphine, it must be concluded that there are significant molecular consequences of noxious stimulation in some spinal cord neurons, even under conditions in which neuronal activity has been suppressed by opioids. Both of these possibilities have important relevance to the generation of pain and are discussed below.
Retrograde labeling from the parabrachial area Although the technique of double labeling may have caused an artifactual reduction ofeither the number of retrogradely labeled or Fos-immunoreactive neurons, this is unlikely for two reasons. First, the distribution of retrogradely labeled cells that we found is identical to that previously reported for the spinoparabrachial neurons in the superficial dorsal horn, the lateral spinal nucleus, the reticulated area ofthe dorsal horn and adjacent white matter, and the area of the central canal (Cechetto et al., 1985; Panneton and Burton, 1985; Wiberg et al., 1987; Bernard et al., 1989; Hylden et al., 1989; Menttrey and de Pommery, 199 1; Menetrey et al., 1992; Kitamura et al., 1993) . Second, the average number of retrogradely labeled cells that we recorded per section was equivalent to the highest numbers reported with other tracers (Menetrey and de Pommery, 199 1; Kitamura et al., 1993) . We therefore believe that the pattern of labeling identified by immunocytochemical localization of Fluoro-gold provides an accurate measure of the number of neurons at the origin of the spinoparabrachial pathway. It is unlikely that we missed a subpopulation of spinoparabrachial neurons.
What stimulates c-fos expression in spinoparabrachial neurons?
Since both the pain behavior and the increased c-fos expression are prevented if the formalin injection is preceded by local anesthetic block of the peripheral nerve or by dorsal rhizotomy (Coderre et al., 1990; Abbadie et al., 1992) , it is clear that primary afferent activity is required. Furthermore, since formalin selectively activates small-caliber primary afferent fibers, the majority of which are nociresponsive (Dickenson and Sullivan, 1987; Heapy et al., 1987) , and since neonatal capsaicin treatment, which reduces the number ofsmall-diameter primary afferent fibers, significantly decreases noxious stimulus-evoked expression of c-fos in the spinal cord (Hylden et al., 1992) we conclude that activation of small-diameter nociceptive primary afferents is necessary. Consistent with this conclusion, the distribution of Fos-like-immunoreactive neurons in the superficial dorsal horn is in the region of termination of small-diameter primary afferents from the tibia1 nerve (Woolf and Fitzgerald, 1986) which innervates the plantar aspect of the hindpaw where the formalin mjection was made. In fact, light microscopic studies demonstrated that small-caliber primary afferents terminate on spinoparabrachial neurons and electrophysiological studies established that spinoparabrachial neurons in laminae I and 110, and their target neurons in the parabrachial area, predominantly respond to noxious stimulation Light et al., 1987 Light et al., , 1993 Bernard and Besson, 1990; Nahin et al., 199 1) . Although some lamina I and 110 spinoparabrachial neurons respond to innocuous cooling (Light et al., 1993) it is unlikely that they are activated by the formalin stimulus; the latter is accompanied by hyperemia and thus raised temperature of the affected foot.
The sign$cance of c-fos expression in spinoparabrachial neurons during morphine analgesia As indicated above, one interpretation of the maintained expression of the c-fos gene in subpopulations of spinoparabrachial neurons of rats rendered analgesic is that despite the morphine, some nociceptive information is still transferred to the brainstem. If these neurons are indeed active, what might be the spinoparabrachial neurons do not normally contribute to the pain behavior that is evoked by a noxious stimulus. Rather, under physiological conditions, that is, in the absence of exogenously administered opioids, activity in these neurons may activate descending antinociceptive circuits that originate in the PAG or in the anterior pretectal nucleus (Basbaum and Fields, 1984; Rees and Roberts, 1993) ; that is, they might engage antinociceptive circuits as part of a negative feedback system that is activated by noxious stimulation. Anterograde tracing studies of parabrachial projections have, in fact, demonstrated a significant projection to the PAG (J. F. Bernard, personal comconsequence of this activity? Two possibilities can be considmunication) and retrograde tracer injections in the anterior preered.
tectal nucleus label neurons in the lateral parabrachial area (Foster First, it is possible that the output of laminae I, 110, and X et al., 1989) . The output ofthe spinoparabrachial neurons would spinoparabrachial neurons is, in fact, pronociceptive, but that enhance the antinociceptive controls induced by morphine. Since the information transmitted by this population of neurons, by such a system would be counterproductive if the spinoparabraitself, is not sufficient to generate pain behavior in the formalin chial neurons that trigger descending controls were themselves test. Since there is evidence that the spinoparabrachial pathway inhibited from the brainstem, to operate effectively these spiprovides nociceptive information to the circuitry that engages noparabrachial neurons would have to be less susceptible to emotional behavior, via the connections of the parabrachial descending inhibitory controls. Mokha (1993) in fact, recorded region with the amygdala it is conceivable from nociresponsive neurons in the medullary dorsal horn and that pain behavior is manifested only when activity in neurons found that while systemic morphine uniformly inhibited the of other pathways such as the spinothalamic tract occurs sifiring of neurons in the region of lamina V, it enhanced the multaneously. That is, the output of nociresponsive spinal cord activity of one-third of neurons located in the superficial lamneurons whose activity is blocked by morphine may provide inae. McMahon and Wall (1988) also reported on a population the discriminative aspect of the nociceptive message that is integrated at supraspinal sites with the "affective" component of the message that is transmitted by the spinoparabrachialamygdala pathway.
It is, of course, also possible that the output of these subpopulations of spinoparabrachial neurons contributes to the pain behavior, but that morphine blocks information transfer from these neurons at higher levels of the neuraxis, in the parabrachial area itself, or in the amygdala. The presence of a high density of I-opioid receptors in the dorsal parabrachial area (Xia and Haddad, 1991) and the fact that systemic morphine markedly depresses the firing of parabrachioamygdaloid projection neurons in response to a noxious stimulus (Huang et al., 1993) are consistent with this hypothesis.
of neurons in the superficial dorsal horn that are excited by electrical stimulation of the dorsolateral funiculus (DLF), the pathway through which many descending inhibitory controls are exerted. This population of neurons may correspond to the spinoparabrachial neurons that we identified in the present study.
The second interpretation of our results is diametrically apposed to the first. It follows from the assumption that neuronal activity in all populations of spinoparabrachial neurons is blocked by morphine, but that noxious stimulus-evoked c-fos expression in subpopulations persists. Conceivably, the primary afferent neurotransmitter-evoked changes in postsynaptic Ca*+ levels can induce c-fos expression, and all of the molecular changes secondary to the increased amount of Fos protein, even though the membrane potential change produced is not sufficient to The central canal area, where many double-labeled cells were seen in morphine-treated animals, receives a dense visceral afferent input, and many neurons in this region respond to noxious stimulation and to visceral afferent inputs (Honda, 1985; Honda and Perl, 1985) . There is considerable evidence that the spinoparabrachial projection is involved in the generation of autonomic reflexes. For example, a stressful stimulus induces c-fos expression in neurons of the parabrachial region (Ceccatelli et al., 1989) . Stimulation of the lateral parabrachial area, where viscerosensory relay neurons are found (Herbert et al., 1990; Jhamandas et al., 1991) evokes a variety of autonomic responses (Mraovitch et al., 1982; Ward, 1988; Dick et al., 1992; Jhamandas and Harris, 1992; Takayama and Miura, 1993) , which suggests that activation of this area initiates autonomic reflex responses to noxious stimulation. The extent to which these reflexes are blocked by an analgesic dose of morphine was not tested in our studies. Conceivably, the autonomic and sensory discriminative consequences of a noxious stimulus are difinduce activity. The implications of this mechanism are significantly different from that described above. Specifically, since the production of the Fos protein is but the first step in a cascade of molecular changes in the neuron (only a few of which have been identified; e.g., Naranjo et al., 199 l) , these results indicate that noxious stimuli can evoke long-term changes in neurons even though activity in the neuron is blocked.
Recent studies have demonstrated that noxious stimulation can, in fact, evoke a long-term sensitization of dorsal horn neurons. These changes require activity of C-fiber primary afferents and can be blocked by the NMDA antagonist MK-801 (Woolf and Thompson, 199 1) . Among the long-term changes recorded are increased receptive field size and lowered threshold to subsequent stimulation. Since c-fos induction may contribute to these changes, the possibility must be considered that such noxious stimulus-evoked changes can be induced in dorsal horn neurons even when the behavioral and electrophysiological consequences of the stimulus are blocked by morphine. ferentially regulated by opiates in the formalin paradigm. The fact that many projection neurons in the central canal area expressed c-fos under conditions of morphine analgesia is also consistent with this view.
A corollary of the first hypothesis is that these nociresponsive
How could morphine block neuronal activity in these neurons, without blocking the expression ofthe c-fosgene? Although there is evidence that morphine can presynaptically inhibit inputs to dorsal horn neurons, by blocking the release of primary afferent neurotransmitters (Suarez-Rota and Maixner, 1992), it is unlikely that this mechanism operates upon these neurons. A presynaptic action of morphine would presumably prevent both the neurotransmitter-evoked activity and c-fos induction. It follows that the predominant inhibitory effect of morphine on these neurons must be postsynaptic, that is, hyperpolarization without blockade of c-fos induction.
Summary
Our results indicate that under conditions of morphine analgesia two distinct populations of spinoparabrachial neurons can be recognized on the basis of their expression of the c-fos gene in response to noxious stimulation. Morphine blocked noxious stimulus-evoked c-fos expression in spinoparabrachial projection neurons concentrated in the neck of the dorsal horn. Morphine was without effect on the expression of c-fos in spinoparabrachial projection neurons of the superficial dorsal horn and in the area around the central canal. Our interpretation of the increased production of the Fos protein in nociresponsive neurons during morphine analgesia depends on the relationship ofneuronal activity to c-fos expression. Either spinal nociceptive transmission in subpopulations of neurons can persist during morphine analgesia, or the present results could be indicative of long-term molecular changes in nociresponsive neurons even though neuronal activity is blocked.
